Retinoids and malignant melanoma: A pathway of proliferation inhibition on SK MEL28 cell line

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 13-19

  Emionite, Laura ^a   Galmozzi, Fabia ^a   Raffo, Patrizia ^a   Vergani, Laura ^a   Toma, Salvatore ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Malignant melanoma; Selective retinoids; SK MEL 28 cell line

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; RETINOID; RETINOID X RECEPTOR; RO 25 7386; RO 41 5253; RO 44 4753; RO 48 2249; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; DRUG EFFECT; DRUG EFFICACY; GENE TARGETING; GROWTH INHIBITION; MALIGNANT TRANSFORMATION; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIVISION; GENE EXPRESSION PROFILING; HUMANS; MELANOMA; RECEPTORS, RETINOIC ACID; RETINOIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0037233744     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. DeVita VT Jr, Hellman S and Rosenberg SA. In: Cancer Principles & Practice of Oncology. 6th Edition. Lippincott Williams & Wilkins Philadelphia USA Editions.
2. Sporn MB, Roberts AB and Goodman DWS: The Retinoids, Biology, Chemistry and Medicine, II Ed., Raven Press, NY, 1994.
3. Chambon P: The retinoid signaling pathway: molecular and genetic analysis. Semin Cell Biol 5(2): 115-125, 1994.
4. Chambon P: A decade of molecular biology of retinoic acid receptors. FASEB J 10 (9): 940-9154, 1996.
5. Lippman SM and Lotan R: Advances in the development of retinoids as chemopreventive agents. J Nutr 130 (2S): 479S-482S, 2000.
6. Lippman SM, Kessler JF and Meyskens FL: Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71: 391-405 (part 1), 493-515 (part 2), 1989.
7. Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ and De Luca LM: Retinoids chemoprevention and differentiation therapy. Carcinogenesis 21(7): 1271-1279, 2000.
8. Miller WH Jr: The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 83(8): 1471-1482, 1998.
9. Mehta RR, Hawthorne ME, Graves JM and Mehta RG: Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells. Eur J Cancer 34(6): 902-907, 1998.
10. Schadendorf D, Worm M, Jurgovsky K, Dippel E, Reichert U and Czarnetzki BM: Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro. Recent Results Cancer Res 139: 183-193, 1995.
11. Schadendorf D, Kern M, Artuc M, Heike LP, Rosenbach T, Fichtner I, Nürnberg W, Stüting S, Stebut E, Worm M, Makki A, Jurgovsky K, Kolde G and Henz BM: Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol 135(6): 1889-1898, 1996.
12. Danielsson C, Törmä H, Vahlquist A and Carlberg C: Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis. Int J Cancer 81: 467-470, 1999.
13. Spanjaard RA, Ikeda M, Lee PJ, Charpentier B, Chin WW and Eberlein TJ: Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RAR-γ in induction of differentiation and apoptosis of S91 melanoma cells. J Biol Chem 272 (32): 18990-18999, 1997.
14. Siegrist W, Hintermann E, Roggo CN, Apfel CM, Klaus M and Eberle AN: Melanoma cell growth inhibition and melanocortin receptor downregulation induced by selective and non-selective retinoids. Melanoma Res 8: 113-122, 1998.
15. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W and Klaus M: A retinoic-acid-receptor-α antagonist selectively counteracts retinoic acid effects. Proc Nat Acad Sci USA 89: 7129-7133, 1992.
16. Majewski S, Marczak M, Szmurlo A, Jablonska S and Bollag W: Retinoids, interferon-α, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR-α mediates the anti-angiogenic effect of retinoids. Cancer Lett 89: 117-124, 1995.
17. Toma S, Isnardi L, Raffo P, Riccardi L, Dastoli G, Apfel C, LeMotte P and Bollag W: RAR-α antagonist RO 41-5253 inhibits proliferation and induces apoptosis in breast cancer cell lines. Int J Cancer 78: 86-94, 1998.
18. Eckhardt K and Schmitt G: A retinoic acid receptor alpha antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo. Toxicol Lett Feb 15: 70(3): 299-308, 1994.
19. Cheung B, Hocker JE, Smith SA, Norris MD, Haber M and Marshall GM: Favorable prognostic significance of high-level retinoic acid receptor-β expression in neuroblastoma mediated by effects on cell cycle regulation. Oncogene 17: 751-759, 1998.
20. Sirchia SM, Ren M, Pili R, Sieroni E, Somenzi G, Ghidoni R, Toma S, Nicolo G and Sacchi N: Endogenous reactivation of the RAR-β2 tumor suppressor gene epigenetically silenced in breast cancer. Canc Res 62: 2455-2461, 2002.
21. Desai SH, Boskovic G, Eastham L, Dawson M and Niles RM: Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells. Biochemical Pharm 59: 1265-1275, 2000.
22. Wu Q, Dawson MI, Zheng Y, Hobbs PD, Agadir A, Jong L, Li Y, Liu R, Lin B and Zhang XK: Inhibition of trans-retinoic acid resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol 17: 6598-6608, 1997.
23. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Graupner G, Lu XP and Pfahl M: A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372: 107-111, 1994.
24. Gandarillas A, Davies D and Blanchard JM: Normal and c-Mycpromoted human keratinocyte differentiation both occur via novel cell cycle involving cellular growth and endoreplication. Oncogene 19: 3278-3289, 2000.